Skip to Main Content

Matt helps developers and innovators in the healthcare industry protect their ideas through patent strategies and dispute resolution.

Matt, as a registered patent attorney and intellectual property litigator, advocates for clients in patent litigation and post-grant proceedings, including litigation arising under the Hatch-Waxman Act. In addition to his litigation and post-grant practice, Matt has extensive experience developing global patent prosecution strategies, drafting legal opinions and licensing agreements, and performing patentability and freedom-to-operate analyses. Matt has experience in numerous biotechnological areas, including but not limited to:

  • Pharmaceuticals & biologics
  • Chemotherapeutics (both large and small molecule)
  • Antibodies and derivatives thereof
  • Cell-based therapeutics (including CAR-T cells)
  • Host cells, genetic vectors and vaccines
  • Recombinants
  • Methods related to the purification and production of target proteins
  • DNA and RNA cloning and amplification techniques
  • Medical devices

Clients value Matt’s prior experience as patent counsel in the oncology division of one of the world's leading biopharmaceutical companies, where he oversaw and developed the patent estates of oncology pipeline biologics. In addition to his legal practice, Matt earned his M.S. in Medical Cannabis Sciences and Therapeutics, developing a heightened understanding of the scientific and clinical uses of the cannabis plant to augment his legal perspectives on cannabis-related issues.




  • Best Lawyers: Ones to Watch, Litigation - Intellectual Property, 2021-2023; Intellectual Property Law, 2023
  • Illinois Super Lawyers, Rising Star, 2021-2023


  • J.D., University of Illinois College of Law
    • cum laude
  • M.S., University of Maryland School of Pharmacy
    • Medical Cannabis Sciences and Therapeutics
  • B.S., University of Illinois at Urbana-Champaign
    • magna cum laude
    • Bronze Tablet
    • Phi Beta Kappa
    • Molecular and Cellular Biology


  • Illinois
  • U.S. Court of Appeals, Federal Circuit
  • U.S. District Court, Northern District of Illinois
  • U.S. Patent and Trademark Office

Professional Memberships and Certifications

  • American Inns of Court, Linn Inn Alliance

The way Husch Blackwell leadership has handled our mental health, our safety, our families – they are unbelievably concerned about us.

  • Defended leading automotive manufacturer against engine component patent infringement claims and successfully rendered patent-in-suit unpatentable on multiple grounds at the Patent Trial and Appeal Board (PTAB).
  • Advised leading biosimilar client regarding litigation strategies for multiple biopharmaceuticals subject to the Biologics Price Competition and Innovation (BPCIA) Act.
  • Managed the global patent prosecution and post-grant strategies for variety of cutting-edge, biologic pipeline products in collaboration with scientists, regulatory agencies, marketing strategists and other key personnel during product discovery and clinical development.
News Releases | December 06, 2021
Husch Blackwell Elects 36 to 2022 Partnership Class
News Releases | October 15, 2021
Husch Blackwell Scores Victory for Sigmapharm in Hatch-Waxman Litigation

Husch Blackwell successfully defended Sigmapharm Laboratories, LLC in connection with its application for approval of a generic version of the antidepressant vortioxetine.

Media Mentions | October 2020
Best Lawyers® 2021: The Midwest Issue
Outside the Office

Matt enjoys writing, cartooning and spending time with his wife and son.

Community Leadership

Matt regularly donates his legal skills to pro bono cases.

He has represented multiple inmates alleging constitutional violations arising from their medical care and conditions of confinement. He has also worked with Wills for Heroes, drafting wills for law enforcement personnel.